Literature DB >> 12670391

The PI-3 kinase/Akt pathway and T cell activation: pleiotropic pathways downstream of PIP3.

Lawrence P Kane1, Arthur Weiss.   

Abstract

Ligation of the T cell receptor for antigen (TCR) and/or costimulatory receptor CD28 results in rapid activation of phosphoinositide-3 kinase (PI-3 kinase). It remains unclear, however, precisely how this activation occurs and also how the newly generated phospholipid products trigger the various events associated with T cell activation. Here we discuss the current understanding of how PI-3 kinase is activated by the TCR and CD28 and what roles its products play in T cell activation. We also review recent advances in understanding the function of Akt in particular, especially its role in CD28 costimulation. Several functional targets of Akt are discussed in this regard: inducible transcription, cell survival, glucose metabolism, and the cellular translational machinery. These pathways have been associated with TCR/CD28 costimulation, and they have also been implicated as targets of Akt.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12670391     DOI: 10.1034/j.1600-065x.2003.00008.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  88 in total

1.  CARMA1 is required for Akt-mediated NF-kappaB activation in T cells.

Authors:  Preeti Narayan; Brittany Holt; Richard Tosti; Lawrence P Kane
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

2.  Phosphatidylinositol-3 phosphatase myotubularin-related protein 6 negatively regulates CD4 T cells.

Authors:  Shekhar Srivastava; Kyung Ko; Papiya Choudhury; Zhai Li; Amanda K Johnson; Vivek Nadkarni; Derya Unutmaz; William A Coetzee; Edward Y Skolnik
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

3.  Protein transduction as a means of effective manipulation of Cdc42 activity in primary T cells.

Authors:  Irina Tskvitaria-Fuller; Neeta Mistry; Shining Sun; Christoph Wülfing
Journal:  J Immunol Methods       Date:  2006-12-08       Impact factor: 2.303

Review 4.  Molecular mechanisms for adaptive tolerance and other T cell anergy models.

Authors:  Seeyoung Choi; Ronald H Schwartz
Journal:  Semin Immunol       Date:  2007-04-02       Impact factor: 11.130

5.  OX40 complexes with phosphoinositide 3-kinase and protein kinase B (PKB) to augment TCR-dependent PKB signaling.

Authors:  Takanori So; Heonsik Choi; Michael Croft
Journal:  J Immunol       Date:  2011-02-02       Impact factor: 5.422

6.  Cutting edge: PHLPP regulates the development, function, and molecular signaling pathways of regulatory T cells.

Authors:  Scott J Patterson; Jonathan M Han; Rosa Garcia; Kiran Assi; Tianyan Gao; Audrey O'Neill; Alexandra C Newton; Megan K Levings
Journal:  J Immunol       Date:  2011-04-15       Impact factor: 5.422

Review 7.  Differential T-cell receptor signals for T helper cell programming.

Authors:  Penelope A Morel
Journal:  Immunology       Date:  2018-05-25       Impact factor: 7.397

Review 8.  Peripheral T cell lymphomas: from the bench to the clinic.

Authors:  Danilo Fiore; Luca Vincenzo Cappelli; Alessandro Broccoli; Pier Luigi Zinzani; Wing C Chan; Giorgio Inghirami
Journal:  Nat Rev Cancer       Date:  2020-04-06       Impact factor: 60.716

9.  Focal adhesion kinase mediates the interferon-gamma-inducible GTPase-induced phosphatidylinositol 3-kinase/Akt survival pathway and further initiates a positive feedback loop of NF-kappaB activation.

Authors:  Zhen Liu; Huifang M Zhang; Ji Yuan; Travis Lim; Alhousseynou Sall; Gregory A Taylor; Decheng Yang
Journal:  Cell Microbiol       Date:  2008-04-28       Impact factor: 3.715

10.  Chimeric antigen receptors combining 4-1BB and CD28 signaling domains augment PI3kinase/AKT/Bcl-XL activation and CD8+ T cell-mediated tumor eradication.

Authors:  Xiao-Song Zhong; Maiko Matsushita; Jason Plotkin; Isabelle Riviere; Michel Sadelain
Journal:  Mol Ther       Date:  2009-09-22       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.